SAN FRANCISCO, Aug. 1, 2018 /PRNewswire/ -- Halo Labs, a venture-backed scientific instrumentation company developinghigh-throughput biopharmaceutical quality control tools, today announced the appointment of Robert Wicke as Chief Executive Officer.
Robert is a seasoned executive with over 25 years of experience growing successful
"We are thrilled to have someone with Robert's successful and extensive background in bringing life science products to market join Halo Labs. His passion for developing high-quality scientific tools that target critical customer problems aligns perfectly with our company vision," said Dr. Bernardo Cordovez, Founder and Chief Scientific Officer. "We look forward to Robert's proven track record of growth taking us to the next level."
"I am very excited and honored to join Halo Labs as they expand both their product portfolio and reach in the biopharmaceutical tools space," said Robert Wicke. "We have a fantastic team and a great product in the HORIZON. I am eager to start building on the existing success of the company."
Robert Wicke succeeds Dr. Robert Hart who is transitioning to Chief Technology Officer where he will focus on innovative new products.
About Halo Labs Halo Labs commercializes biopharmaceutical analysis instrumentation. The company was named Philadelphia Life Science Startup of 2012. Halo Labs is venture backed by BioAdvance, BroadOak Capital Partners and the Ben Franklin Technology Partners. Halo Labs' flagship product, the HORIZONŪ, enables for the first time high throughput - low volume subvisible particle analysis and is funded by prestigious small business grants from NIST and the FDA. For more information, please visit www.halolabs.com
View original content:http://www.prnewswire.com/news-releases/robert-wicke-appointed-as-new-ceo-of-halo-labs-300689749.html
SOURCE Halo Labs
Subscribe to our Free Newsletters!